research report · UNH

Unitedhealth Group Inc

Johannes Vermeer, Woman Holding a Balance, c. 1664, detail · National Gallery of Art

Viridis’s deep research report, written Nov 3, 2026 from its quarterly report (10-Q for the quarter ended Sep 30, 2026, filed Nov 3, 2026). Written and checked with Anthropic’s Claude models.

your email, no card; what you get

business trajectory

Improving

better on balance: sales, margins, cash or competitive position

financial resilience

Strong

can meet its obligations and fund its plan for two years with money it can count on, with room

Judgments of the business from its filings, not of its shares: no valuation, no advice.

bottom line

UnitedHealth's profit recovery is real and is turning into cash. It is being earned by repricing a shrinking book of business, and last year's over-reserved claims gave it extra help. Third-quarter operating profit (earnings from operations) rose to $6.6B from $4.3B on flat revenue of $112.7B. Nine-month operating cash flow of $25.1B covered capital spending, acquisitions, dividends and buybacks about 1.65 times (my arithmetic). On my calculation, medical costs for 2026 dates of service ran 87.0% of premiums over nine months, against 88.0% a year earlier. Reserve releases lowered the reported ratio by roughly another 0.7 points. What decides the next leg is whether 2027 pricing stays ahead of a commercial cost trend that management puts above 11%.

what changed this quarter

  • Q3 2026 against Q3 2025:
  • Revenue was $112.7B vs $113.2B.
  • Earnings from operations were $6.6B vs $4.3B.
  • Diluted earnings per share were $4.56 vs $2.59; adjusted EPS was $4.69 vs $2.92.
  • Costs:
  • The medical care ratio (medical costs ÷ premiums) was 88.4% vs 89.9%. That includes $610M of favorable development on earlier-2026 claims.
  • The operating cost ratio was 12.8% vs 13.5%.
  • Guidance: 2026 guidance was raised to at least $20.50 adjusted and at least $19.50 GAAP per share. The release does not restate the prior figure.
  • Capital:
  • A $3.0B acquisition closed July 2, with $1.5B payable within a year.
  • $2.0B of forward share repurchases settled July 1.
  • In November the board authorized up to 50M more shares for buybacks.
  • Membership: UnitedHealthcare served 48.3M people vs 50.1M a year earlier.

in the full report

Its findings, each with the evidence, the strongest counterpoint and what would prove it wrong:

  • Cost control on 2026 claims has improved; reserve releases flatter the reported ratio further
  • Growth comes from price and from sales inside the group; the insured book keeps shrinking
  • The full-year floor looks conservative: it needs only $2.20 in the fourth quarter
  • Tax and Medicare legal exposures stay open and outside the numbers

Then its finances, the quality of its earnings, its management, the case for and against, and what to watch, its claims cited to the filings and checked against them.

read it whole

Your email and the code we send it, no card. The report then opens: a free account has 2 free reports a month from the library, the reports already written. Already have a Viridis account? Use its email, and the report goes on it. You also see what UNH files, free: its deadlines and its red flags.

Subscribe: your plan’s reports work on any company that files with the SEC, written for you if nobody has asked yet, and each new one on the companies you choose comes as they file.

In Claude or ChatGPT, ask: “What does Viridis's report on UNH say?” Add Viridis to Claude, or to ChatGPT.